Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxel (Q28287239)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxel |
scientific article |
Statements
Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxel (English)
Carlos M Galmarini
Isabelle Treilleux
Virginie Durbecq
David Gancberg
Marie-Christine Bissery
Marianne Paesmans
Denis Larsimont
Martine J Piccart
Chantal Bernard-Marty